TY  - GEN
AB  - Chronic wounds, defined as wounds which have not healed over an expected 6-week timeframe, are a common and costly burden among individuals of all ages and backgrounds. Current estimations of disease burden indicate that 2% of the United States (US) population is affected by chronic wounds. Many interventions have been proposed to address the burden of chronic wounds, including hydrocolloid gels, collagen, anti-fungal therapy, and non-adhesive bandages. There remains significant debate over which wound care products are truly efficacious. In recent years, a growing body of evidence has emerged which promotes topical timolol as effective treatment of chronic wounds.  To date, however, there exists limited consensus on Timolol's efficacy and safety in this setting. This project seeks to identify and systematically review the current literature on the use of timolol in the treatment of chronic wounds.
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AD  - Oregon Health and Science University
AU  - Cornwell, David
AU  - Chrea, Bopha
AU  - McLafferty, Robert
DA  - 2021
DO  - 10.6083/bc386k002
DO  - DOI
ID  - 9211
KW  - Diabetic Foot
KW  - Timolol
KW  - Foot Ulcer
KW  - Diabetes Complications
KW  - chronic wounds
KW  - beta adrenergic blocker
KW  - wound care
L1  - https://digitalcollections.ohsu.edu/record/9211/files/Goldstein-Zachary-OHSU-ResearchWeek-2021.pdf
L2  - https://digitalcollections.ohsu.edu/record/9211/files/Goldstein-Zachary-OHSU-ResearchWeek-2021.pdf
L4  - https://digitalcollections.ohsu.edu/record/9211/files/Goldstein-Zachary-OHSU-ResearchWeek-2021.pdf
LK  - https://digitalcollections.ohsu.edu/record/9211/files/Goldstein-Zachary-OHSU-ResearchWeek-2021.pdf
N2  - Chronic wounds, defined as wounds which have not healed over an expected 6-week timeframe, are a common and costly burden among individuals of all ages and backgrounds. Current estimations of disease burden indicate that 2% of the United States (US) population is affected by chronic wounds. Many interventions have been proposed to address the burden of chronic wounds, including hydrocolloid gels, collagen, anti-fungal therapy, and non-adhesive bandages. There remains significant debate over which wound care products are truly efficacious. In recent years, a growing body of evidence has emerged which promotes topical timolol as effective treatment of chronic wounds.  To date, however, there exists limited consensus on Timolol's efficacy and safety in this setting. This project seeks to identify and systematically review the current literature on the use of timolol in the treatment of chronic wounds.
PB  - Oregon Health and Science University
PY  - 2021
T1  - Topical Timolol for treatment of chronic wounds: a systematic review
TI  - Topical Timolol for treatment of chronic wounds: a systematic review
UR  - https://digitalcollections.ohsu.edu/record/9211/files/Goldstein-Zachary-OHSU-ResearchWeek-2021.pdf
Y1  - 2021
ER  -